Nirmish Shah

Nirmish Shah

Auto-generated profile, based on publicly available information

Nirmish Shah

Department of Hematology, Duke University School of Medicine, Durham, NC

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Sherif M. BadawySherif M. Badawy
Sherif M. Badawy
RCRobert M Cronin
Robert M Cronin
JHJane S Hankins
Jane S Hankins
LCLori Crosby
Lori Crosby
MDMichael DeBaun
Michael DeBaun
NSNirmish Shah
Nirmish Shah
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Sickle cell disease (SCD) is an inherited blood disorder that affects over 100,000 Americans. SCD-related complications lead to significant morbidity and early mortality. There is a growing evidence to support the feasibility, acceptability and efficacy of self-management e-health interventions in chronic diseases; however, the evidence is unclear in SCD. Objective: We systematically evaluated the most recent evidence of the literature to: (1) review the different types of technological tools used for self-management in SCD, (2) to discover and describe what self-management activities these tools were used for, and (3) to assess the efficacy of these technologies in self-management. Methods: This review covered literature published between 1995 and 2016 with no language limits. Searches included PubMed MEDLINE, Embase, CINAHL, PsycINFO and other sources. We followed the guidelines for the preferred reporting items for systematic reviews and meta-analyses (PRISMA). Two independent reviewers screened titles and abstracts, assessed full-text articles, and extracted data from articles that met inclusion criteria. Eligible studies were original research articles that included texting, mobile phone–based apps or other e-health interventions designed to improve self-management in pediatric and adult patients with SCD. Results: Of 1680 citations, only 16 articles met all predefined criteria with a total of 747 study participants. Interventions included text-messaging (4/16, 25%), native mobile apps (3/16, 19%), web-based applications (5/16, 31%), mobile directly observed therapy (2/16, 13%), Internet-delivered cognitive behavioral therapy (2/16, 13%), electronic pill bottle (1/16, 6%), or interactive gamification (2/16, 13%). Interventions targeted monitoring and/or improvement of medication adherence (5/16, 31%); self-management, pain and symptoms reporting (7/16, 44%); stress, coping, sleep and daily activities reporting (4/16, 25%); cognitive training for memory (1/16, 6%); SCD and reproductive health knowledge (5/16, 31%); cognitive behavioral therapy (2/16, 13%) and guided relaxation interventions (1/16, 6%). Most studies (11/16, 69%) included older children or adolescents (mean or median age 10-17 years old), 5 included young adults (≥18 years old) (5/16, 31%), and only 2 allowed parents to participate (2/16, 13%). Sample size ranged from 11 to 236, with a median of 21 per study; < 20 in 6 (38%), ≥ 20 to < 50 in 6 (38%), and >50 participants in 4 studies (25%). Study design was pre-post pilot or feasibility trials in 7 (44%), randomized controlled trials (RCT) in 5 (31%), single-arm observational studies in 2 (13%), quasi-experimental in 1 (6%), and retrospective in 1 study (6%). All studies were performed in the United States. The duration of the intervention ranged from 3 days to 12 months as follows: ≤ 3 months in 7 (44%), > 3 and ≤ 6 months in 5 (31%), or > 6 and up to 12 months in 2 studies (13%). Retention rates were < 80% in 4 (25%), ≥ 80% and < 100% in 6 (38%), 100% in 1 (6%), and not reported in 5 studies (31%). Only 6 studies (38%) were informed by a clear theoretical framework for their intervention effects, including Health Belief Model; Theory-based Game Design; Gate Control Theory; Transactional Stress Model; Coping Theoretical Model; Theory of Reasoned Action; and Kolb Experiential Learning Theory. Most reported improvement in self-management related outcomes (15/16, 94%) as well as high satisfaction and acceptability of different study interventions (10/16, 63%). Conclusions: Our systematic review identified a number of e-health interventions measuring a variety of outcomes, which showed improvement in multiple components of self-management in SCD. Despite the promising feasibility and acceptability of e-health interventions in improving self-management in SCD, the evidence overall is modest. Future e-health intervention studies are needed to evaluate their efficacy, effectiveness, and cost-effectiveness in promoting self-management in patients with SCD using rigorous methods and theoretical frameworks with clearly defined clinical outcomes. Clinical Trial: N/A

29 January 2014 in Hemoglobin
Verified
Journal Article
Closed access
NSNirmish Shah
Nirmish Shah
JJJude Jonassaint
Jude Jonassaint
LCLaura De Castro
Laura De Castro
The widespread use of mobile phones among patients provides a unique opportunity for the development of mobile health intervention designed specifically for sickle cell disease, which will improve self-management as well as health care delivery. Our objective was to determine the receptiveness of patients with sickle cell disease to technology and a mobile application (app) designed for sickle cell disease. Phase I included 100 patients who completed a survey inquiring about receptiveness to technology and use of mobile devices to self-manage and communicate with providers. Phase II surveyed 17 additional patients who tested a newly developed sickle cell disease app, to report its usability and utility. In Phase I, on a 0-10 Likert scale where 0 is not comfortable, and 10 is extremely comfortable, 87.0% of participants reported >5 comfort level using a mobile device for health care management. Participants were comfortable with texting (81.0%) and emailing (77.0%) but not with social media (40.0%). Most participants (84.0%) owned computer devices (desktops, laptops, tablets, or iPads), and 92.0% owned mobile devices. In Phase II, participants reported that the app tested was useful to track pain (88.0%), and 94.0% reported that it was easy to use, practical, and useful for health self-management. All reported that the app was useful to help one communicate with providers. Following the use of our app, patients found it an extremely valuable tool for tracking pain, health management, and communicating with providers. We conclude that mobile technology might provide an appropriate venue for sickle cell disease healthcare management.

1 April 2015 in Hemoglobin
Verified
Journal Article
Closed access
CJCharles R. Jonassaint
Charles R. Jonassaint
NSNirmish Shah
Nirmish Shah
JJJude Jonassaint
Jude Jonassaint
LCLaura De Castro
Laura De Castro
Patients with sickle cell disease frequently experience severe pain events that lead to unplanned healthcare utilization. Mobile health tools (mHealth) may help prevent these events by providing remote monitoring and self-management support. This article describes the feasibility of the Sickle cell disease Mobile Application to Record symptoms via Technology (SMART), an mHealth app developed to help sickle cell disease patients monitor and manage their day-to-day symptoms. Fifteen patients recorded their pain intensity using a paper visual analog scale (VAS) and then repeated this measurement using an electronic VAS pain measure on SMART. Patients continued using SMART to record clinical symptoms, pain intensity, location and perceived severity, and treatment strategies for at least 28 days. Patient median age was 29 years (range 16-54); 60.0% were male. There was a high intraclass correlation between pain measurements entered on the paper VAS and SMART on the iPhone and the iPad We found a strong association between patient perceived pain severity and pain intensity entries using SMART (b = 1.71; p < 0.01). Daily compliance with SMART entries was a mean 75.0%, with a high of 85.7% in week 1 and low of 57.9% in week 4; however, one-third (n = 5) of the patients were 100.0% compliant even in week 4. Patients who were over age 35 or used an iPad for the study had the highest compliance rates. This study showed that SMART is a useable and feasible method for monitoring daily pain symptoms among adolescents and adults with sickle cell disease-related pain.

23 March 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SPShannon Phillips
Shannon Phillips
YCYumei Chen
Yumei Chen
RMRita Masese
Rita Masese
LNLaurence Noisette
Laurence Noisette
KJKasey Jordan
Kasey Jordan
JKJulie Kanter
Julie Kanter
Introduction: Sickle cell disease (SCD) is an inherited hemoglobinopathy that predominantly affects African Americans in the United States. The disease is associated with complications leading to high healthcare utilization rates, including emergency department (ED) visits and hospitalizations. Optimal SCD care requires a multidisciplinary approach involving SCD specialists to ensure preventive care, minimize complications and prevent unnecessary ED visits and hospitalizations. However, most individuals with SCD receive sub-optimal care or are unaffiliated with care (have not seen an SCD specialist). We aimed to identify barriers to care from the perspective of individuals with SCD in a multi-state sample. Methods: We performed a multiple methods study consisting of surveys and interviews in three comprehensive SCD centers from March to June 2018. Interviews were transcribed and coded, exploring themes around barriers to care. Survey questions on the specific themes identified in the interviews were analyzed using summary statistics. Results: We administered surveys to 208 individuals and conducted 44 in-depth interviews. Barriers to care were identified and classified according to ecological level (i.e., individual, family/interpersonal, provider, and socio-environmental/organizational level). Individual-level barriers included lack of knowledge in self-management and disease severity. Family/interpersonal level barriers were inadequate caregiver support and competing life demands. Provider level barriers were limited provider knowledge, provider inexperience, poor provider-patient relationship, being treated differently, and the provider’s lack of appreciation of the patient’s SCD knowledge. Socio-environmental/organizational level barriers included limited transportation, lack of insurance, administrative barriers, poor care coordination, and reduced access to care due to limited clinic availability, services provided or clinic refusal to provide SCD care. Conclusion: Participants reported several multilevel barriers to SCD care. Strategies tailored towards reducing these barriers are warranted. Our findings may also inform interventions aiming to locate and link unaffiliated individuals to care.

2 December 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
AJAmanda Johnson
Amanda Johnson
FYFan Yang
Fan Yang
SGSiddharth Gollarahalli
Siddharth Gollarahalli
WUWright University
Wright University
DADaniel Abrams
Daniel Abrams
NSNirmish Shah
Nirmish Shah
Background: Sickle cell disease (SCD) is an inherited red blood cell disorder affecting millions worldwide, and it results in many potential medical complications throughout the life course. The hallmark of SCD is pain. Many patients experience daily chronic pain as well as intermittent, unpredictable acute vaso-occlusive painful episodes called pain crises. These pain crises often require acute medical care through the day hospital or emergency department. Following presentation, a number of these patients are subsequently admitted with continued efforts of treatment focused on palliative pain control and hydration for management. Mitigating pain crises is challenging for both the patients and their providers, given the perceived unpredictability and subjective nature of pain. Objective: The objective of this study was to show the feasibility of using objective, physiologic measurements obtained from a wearable device during an acute pain crisis to predict patient-reported pain scores (in an app and to nursing staff) using machine learning techniques. Methods: For this feasibility study, we enrolled 27 adult patients presenting to the day hospital with acute pain. At the beginning of pain treatment, each participant was given a wearable device (Microsoft Band 2) that collected physiologic measurements. Pain scores from our mobile app, Technology Resources to Understand Pain Assessment in Patients with Pain, and those obtained by nursing staff were both used with wearable signals to complete time stamp matching and feature extraction and selection. Following this, we constructed regression and classification machine learning algorithms to build between-subject pain prediction models. Results: Patients were monitored for an average of 3.79 (SD 2.23) hours, with an average of 5826 (SD 2667) objective data values per patient. As expected, we found that pain scores and heart rate decreased for most patients during the course of their stay. Using the wearable sensor data and pain scores, we were able to create a regression model to predict subjective pain scores with a root mean square error of 1.430 and correlation between observations and predictions of 0.706. Furthermore, we verified the hypothesis that the regression model outperformed the classification model by comparing the performances of the support vector machines (SVM) and the SVM for regression. Conclusions: The Microsoft Band 2 allowed easy collection of objective, physiologic markers during an acute pain crisis in adults with SCD. Features can be extracted from these data signals and matched with pain scores. Machine learning models can then use these features to feasibly predict patient pain scores.

16 October 2019 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
NSNirmish Shah
Nirmish Shah
MBMenaka Bhor
Menaka Bhor
LXLin Xie
Lin Xie
RHRashid Halloway
Rashid Halloway
SASteve Arcona
Steve Arcona
HYHuseyin Yuce
Huseyin Yuce
Background: This study aimed to evaluate sickle-cell disease (SCD) treatment patterns and economic burden among patients prescribed hydroxyurea (HU) in the US, through claims data.Methods: SCD patients with pharmacy claims for HU were selected from the Medicaid Analytic Extracts (MAX) from January 1, 2009 - December 31, 2013. The first HU prescription during the identification period was defined as the index date and patients were required to have had continuous medical and pharmacy benefits for ≥6 months baseline and 12 months follow-up periods. Patient demographics, clinical characteristics, treatment patterns, health care utilization, and costs were examined, and variables were analyzed descriptively.Results: A total of 3999 SCD patients prescribed HU were included; the mean age was 19.24 years, most patients were African American (73.3%), and the mean Charlson comorbidity index (CCI) score was 0.6. Asthma (20.3%), acute chest syndrome (15.6%), and infectious and parasitic diseases (20%) were the most prevalent comorbidities. During the 12-month follow-up period, 58.9% (N = 2357) of patients discontinued HU medication. The mean medication possession ratio (MPR) was 0.52, and 22.3% of patients had MPR ≥80%. The average length of stay (LOS) for SCD-related hospitalization was 13.35 days; 64% of patients had ≥1 SCD-related hospitalization. The mean annual total SCD-related costs per patient were $27,779, mostly inpatient costs ($20,128).Conclusions: Overall, the study showed the patients had significant unmet needs manifest as poor medication adherence, high treatment discontinuation rates, and high economic burden.